Affibody

company

About

Affibody is a Swedish biotech company focused on developing products for therapy, diagnostic imaging, and other applications.

  • 11 - 50

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€20M
Industries
Biotechnology,Health Care,Health Diagnostics
Founded date
Jan 1, 1998
Number Of Employee
11 - 50
Operating Status
Active

Affibody is a Swedish biotech company focused on developing next generation products for therapy, diagnostic imaging, and other applications based on its unique proprietary technology platforms: Affibody® molecules and Albumod™.

Affibody® molecules, which are small, robust and easily produced, can be designed to bind specifically to a large number of target proteins. They have a broad range of applications including protein purification, enzyme inhibition, research reagents for protein capture and detection, diagnostics, including molecular imaging, and targeted therapeutics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€20M
Affibody has raised a total of €20M in funding over 2 rounds. Their latest funding was raised on Dec 23, 2022 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 23, 2022 Debt Financing €20M 1 European Investment Bank Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Affibody has made 1 investments. Their most recent investment was on Dec 17, 2014, when PeerNova raised $8.60M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 17, 2014 PeerNova
Series A $8.60M Analytics

Investors

Number of Lead Investors
Number of Investors
1
1
Affibody is funded by 1 investors. European Investment Bank are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Debt Financing